Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1097 | 1097 | 1177 | 1284 | 1649 | 2465 |
Fund Return | 9.73% | 9.73% | 17.66% | 8.68% | 10.52% | 9.44% |
Place in category | 254 | 254 | 324 | 268 | 108 | 58 |
% in Category | 33 | 33 | 54 | 55 | 27 | 23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Sparinvest SICAV Balance EUR I | 2.3B | 4.50 | 3.01 | 4.27 | ||
Sparinvest SICAV Procedo EUR I | 1.99B | 5.91 | 4.67 | 5.68 | ||
Sparinvest SICAV Glbl Value EUR I | 1.02B | 10.35 | 10.78 | 9.49 | ||
SparInv SICAV EthicalGlblVal EUR ID | 995.3M | 9.73 | 8.69 | 9.57 | ||
SparInv SICAV Ethical GlblVal EUR R | 39.89M | 9.56 | 7.97 | 8.67 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
R BP Global Premium Equities I | 4.44B | 10.09 | 11.54 | 10.36 | ||
LU1208675808 | 4.44B | 10.08 | 11.51 | - | ||
R BP Global Premium Equities B | 4.44B | 9.91 | 10.82 | 9.64 | ||
R BP Global Premium Equities C | 4.44B | 10.08 | 11.51 | 10.32 | ||
R BP Global Premium Equities D | 4.44B | 9.91 | 10.82 | 9.64 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Travelers | US89417E1091 | 2.99 | 213.49 | -0.23% | |
Citigroup | US1729674242 | 2.97 | 62.64 | +1.38% | |
Regions Financial | US7591EP1005 | 2.62 | 19.61 | 0.03% | |
CVS Health Corp | US1266501006 | 2.60 | 67.19 | -0.21% | |
MetLife | US59156R1086 | 2.60 | 70.42 | -2.06% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review